Clear differences between emerging and more mature markets in pharma sales force levels

15 June 2011

Achieving the right pharmaceutical sales force structure and size are more important than ever in this highly competitive and dynamic environment. Christopher Wooden, vice president for the Cegedim Strategic Data (CSD) Global Promotion Audit observes: "Effective sales force strategy and sizing are essential to achieving brand penetration and competitive share of voice. In mature markets, we see the challenge of ‘right sizing’ and it requires on demand data driven assessment to help optimize constrained resources.”

Meanwhile, he adds, “in emerging markets there is another immediate challenge - building scalable sales force structure with the flexibility to expand and drive growth while simultaneously monitoring and improving call quality and effectiveness. We believe our Sales Force Excellence service is offering the right data resources to help meet these challenges."

Some recent highlights from CSD Sales Force Excellence:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical